NCT06608459View on ClinicalTrials.gov

PEX010-Assisted Therapy for Opioid Use Disorder (OUD): a Feasibility Study

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions
Opioid Use Disorder
Interventions
DRUG

PEX010-Assisted Therapy

The investigational medicinal product PEX010 is a capsule for oral administration that contains the drug substance PYEX.

Sponsors
All Listed Sponsors
collaborator

University of British Columbia

OTHER

lead

Filament Health Corp.

INDUSTRY